Cara Therapeutics
CARA
#10952
Rank
โ‚ฌ7.39 M
Marketcap
4,85ย โ‚ฌ
Share price
-2.56%
Change (1 day)
24.12%
Change (1 year)

EPS for Cara Therapeutics (CARA)

EPS in 2024 (TTM): -19,25ย โ‚ฌ

According to Cara Therapeutics 's latest financial reports the company's current EPS (TTM) is -19,14ย โ‚ฌ. In 2023 the company made an earnings per share (EPS) of -23,85ย โ‚ฌ a decrease over its 2022 EPS that were of -17,39ย โ‚ฌ.

EPS history for Cara Therapeutics from 2013 to 2024

Annual EPS

Year EPS Change
2024 (TTM)-19,25ย โ‚ฌ-19.3%
2023-23,85ย โ‚ฌ37.11%
2022-17,39ย โ‚ฌ-8.09%
2021-18,92ย โ‚ฌ
2019-27,24ย โ‚ฌ20.87%
2018-22,53ย โ‚ฌ7.85%
2017-20,89ย โ‚ฌ-9.05%
2016-22,97ย โ‚ฌ110%
2015-10,94ย โ‚ฌ17.65%
2014-9,30ย โ‚ฌ-3.42%
2013-9,63ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
6,09ย โ‚ฌ-131.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
0,65ย โ‚ฌ-103.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Trevena
TRVN
-31,67ย โ‚ฌ 65.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
-45,86ย โ‚ฌ 139.57%๐Ÿ‡บ๐Ÿ‡ธ USA
AcelRx Pharmaceuticals
ACRX
-2,03ย โ‚ฌ-89.38%๐Ÿ‡บ๐Ÿ‡ธ USA